Checkpoint Genetics Inc. Appoints Richard Newman to Lead Company's Strategic Financial Planning.Business Editors & Health/Medical Writers WEST CHESTER West Chester, borough (1990 pop. 18,041), seat of Chester co., SE Pa., W of Philadelphia; inc. 1799. Primarily residential, West Chester was long the trade and processing center for an agricultural region that is now mainly suburbs. , Pa.--(BW HealthWire)--Dec. 1, 2000 Checkpoint Genetics Inc. today announced the appointment of Richard Newman
Richard Newman is a voice actor with numerous voice roles in Transformers cartoons. as director, finance and administration. Checkpoint Genetics Inc. is a subsidiary of Checkpoint Genetics Pharmaceuticals Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). :CKPT CKPT Checkpoint CKPT Cockpit ). As director, finance and administration, Richard is responsible for all financial reporting and strategic analysis, the finance and accounting support for Checkpoint Genetics Inc., human resources and facility planning, as well as the management of budgeting, forecasting and financial planning Financial planning Evaluating the investing and financing options available to a firm. Planning includes attempting to make optimal decisions, projecting the consequences of these decisions for the firm in the form of a financial plan, and then comparing future performance against . Newman brings to Checkpoint Genetics a strong background in financial management and public accounting. Prior to Checkpoint Genetics, he served as Manager, Corporate Finance, Rhone-Poulenc Rorer and Controller, Convergent Solutions, Inc. Newman graduated from Penn State University with a B.S. in accounting and is also a certified public accountant Certified Public Accountant (CPA) An accountant who has met certain standards, including experience, age, and licensing, and passed exams in a particular state. . Checkpoint Genetics Inc. is a privately-controlled pharmaceutical company focused on the development and commercialization of products for prevention of cardiovascular diseases and the maintenance of heart health. Checkpoint Genetics' proprietary development program is based upon small molecule regulation of cell cycle signals associated with cardiovascular disease. Checkpoint Genetics leverages these developments with commercialization of dietary supplements derived from the active principles of sea-vegetables, an important component of a traditional Japanese diet. A society recognized as having a notably lower incidence of heart disease reflects their marine diet that includes sea-vegetable consumption. Certain statements in this press release constitute "forward-looking statements" that are subject to risks and uncertainties which may cause the actual results of the Company to be different from expectations expressed or implied by such forward-looking statements. Such factors include, but are not limited to, uncertainty of market acceptance of the Company's products, the uncertainty of expenses associated with clinical trials and research efforts which may affect the continued profitability of the Company, uncertainty of regulatory approvals, the timing and content of decisions by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. , the uncertainty of market conditions and other risk factors detailed in the Company's SEC filings. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion